Upstream Bio, Inc. (UPB)

5.195 +0.02 (+0.48%) USD  |  NASDAQ  |  Sep 25, 14:55
More

Upstream Bio Cash from Operations (TTM) : -136.34M for June 30, 2026

Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for UPB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 -136.34M
March 31, 2026 -139.96M
Date Value
December 31, 2025 -133.28M
September 30, 2025 -122.26M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Sutro Biopharma, Inc. -145.17M
Compass Therapeutics, Inc. -56.11M
ACADIA Pharmaceuticals, Inc. 160.32M
Alnylam Pharmaceuticals, Inc. 885.89M
Anika Therapeutics, Inc. 5.977M